Hence, these results showed that ART cytotoxicity was closely related to the genomic status of p53 and Cdk4/6-p16-Rb, indicating that ART is potentially useful for neoadjuvant chemotherapy against ESCC. This evidence concerns the gene CDKN2A and esophageal squamous cell carcinoma.